Home/Filings/4/0001104659-25-032060
4//SEC Filing

Cherington Charles 4

Accession 0001104659-25-032060

CIK 0000748592other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 10:54 AM ET

Size

5.6 KB

Accession

0001104659-25-032060

Insider Transaction Report

Form 4
Period: 2025-04-02
Transactions
  • Purchase

    Common Stock

    2025-04-02$0.10/sh+3,768,397$394,17420,401,602 total
Footnotes (2)
  • [F1]On April 2, 2025, pursuant to a private placement offering by the Issuer, the reporting person acquired 3,768,397 shares of the Issuer's Common Stock.
  • [F2]On December 3, 2024, the Issuer paid a dividend to all holders of record of its Series A Preferred Stock on such date of $0.05 per share of Series A Preferred Stock. Pursuant to the terms of the Series A Preferred Stock, the Issuer elected to pay the dividend in an equivalent amount of common stock. As a result, the Reporting Person received 5,082 shares of the Issuer's common stock.

Issuer

Eterna Therapeutics Inc.

CIK 0000748592

Entity typeother

Related Parties

1
  • filerCIK 0001448698

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 10:54 AM ET
Size
5.6 KB